| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |